同方康泰(01312.HK)2570萬元收購陝西寶雞一處土地使用權
格隆匯 1 月 22日丨同方康泰(01312.HK)公佈,於2021年1月22日,公司的間接非全資附屬公司陝西紫光與寶雞自然資源和規劃局就收購該土地(位於中國陝西省寶雞)的土地使用權訂立土地使用權出讓合同,代價為人民幣2570萬元。
據悉,中國陝西省寶雞市高新技術產業開發區科技新城高新大道以南、創業路以東、產業大道以北,面積69,674.67平方米。
公吿稱,為配合集團醫藥及健康業務的發展及擴充,集團計劃將該土地用於建立主要專門製造中藥的新生產基地。尤其是,綜合辦公樓、綜合車間、中藥庫房及附屬設施將予以興建,以提升集團生產中藥的能力。董事會相信收購事項與集團的整體策略一致,亦有利於醫藥及健康分部的長遠業務發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.